Status:
COMPLETED
Affect Labeling - Experimental Evaluation and Behavioral Intervention
Lead Sponsor:
Karolinska Institutet
Conditions:
Emotional Dysregulation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall aim of this project is to better understand the emotion regulating effect of labeling emotions (affecting labeling, AL) for individuals with self-perceived emotional regulation difficultie...
Detailed Description
Main study: AFFECT LABELING - DAILY EXERCISE IN PUTTING WORDS ON EMOTIONS DESIGN AND PROCEDURE This clinical study is a randomized, wait-list controlled design with repeated measurements. Participants...
Eligibility Criteria
Inclusion
- Sufficient skills in Swedish to be able to fill in self-assessment questionnaires.
- State at least a 3 (or higher) out of 10 regarding everyday difficulties with emotion regulation according to a scale created for this purpose: Do you feel that you currently have problems regulating your emotions? Circle the number that is best for you "(0 no problems at all, 10 Very severe problems.
- Answer "Yes, very much" or "Yes" to the following question: "Would you like to learn to regulate/manage your emotions better?" with the options "Yes, very much / Yes / Maybe, but doubtful if it is worth the effort, does not fit right now / No".
Exclusion
- Psychiatric or somatic status that may prevent the participant from completing the experiment or require some form of care intervention the participant does not already undergo.
- Medium to high risk of suicide.
- Moderate to severe self-harming behavior.
- Blood phobia.
- Regular medication with benzodiazepines (including sleep medication, ex Stilnoct).
- Ongoing treatment with emotion regulation elements.
- To be part of the clinical group, the participant must state a diagnosis established by a medical professional in the last 5 years, which involves clinical difficulties with emotion regulation such as binge eating disorder, emotional instability, generalized anxiety, depression, social anxiety or ADHD, and does not plan to start, change or discontinue any psychosocial or pharmacological treatment within the next 4 weeks. The non-clinical group must not have been diagnosed or treated for mental illness in the last 5 years.
Key Trial Info
Start Date :
January 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2024
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT04826874
Start Date
January 11 2023
End Date
March 1 2024
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institutet, department of clinical neuroscience
Stockholm, Stockholm County, Sweden, 17177